RecallRadar

CPSC recall 26455

Travel Size Afrin® Original Nasal Spray 6 mL Bottles

On 2026-05-01 the CPSC announced a recall of Travel Size Afrin® Original Nasal Spray 6 mL Bottles by Bayer Healthcare, citing the 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison P….

Read the official CPSC notice

AgencyCPSC
Recall number26455
ClassificationNot classified
Statusunknown
Initiated2026-04-30
Published2026-05-01
Last updated2026-09-13 11:58 UTC
CompanyBayer Healthcare
DistributionUS

Product

Travel Size Afrin® Original Nasal Spray 6 mL Bottles | This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have "Afrin® Original Nasal Spray" and "1/5 FL OZ (6 mL)" printed on a label located on the front of the bottle. It is a six-digit number, followed by the expiration date in following format: "YYYYMMM". No other sizes of Afrin are included in this recall.

Reason

The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:58 UTC. Current status: unknown.

Source

Official record: https://www.cpsc.gov/Recalls/2026/Bayer-Recalls-6-mL-Size-Afrin-Original-Nasal-Spray-Bottles-Due-to-Risk-of-Serious-Injury-or-Illness-from-Child-Poisoning-Violates-Mandatory-Standard-for-Child-Resistant-Packaging

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.